Jason Kumpf Capital backs bold operators building durable value at the edges of what is possible — from the first angel check through public-company ownership.
Every voyage worth taking begins with a decision to leave the harbor. The earliest American venture capital was not a spreadsheet exercise — it was a group of people willing to fund a crossing into territory they could not yet see, trusting the character of the people aboard and the durability of the idea more than any guarantee of return. That spirit is the starting point for how we invest at Jason Kumpf Capital. We are drawn to new frontiers and to the people bold enough to chart them, and we measure ourselves by the lasting value those crossings create rather than by how large we become along the way.
At the center of our criteria is the operator. We back people before we back markets, because frontiers reward those who can absorb uncertainty, change course without losing direction, and keep a crew together when the weather turns. We look for founders and leaders who carry an unusual combination of clarity and humility: clear enough about where they are going to make hard tradeoffs, humble enough to keep learning from reality as it pushes back. We pay attention to how someone reasons through a problem they have never seen before, how they treat the people who depend on them, and whether their ambition is matched by the discipline to build something that endures. Conviction, in our experience, is worth more than consensus. The most interesting opportunities are often the ones that look uncomfortable to the broader market — and the ability to hold a considered, independent view through that discomfort is part of what we look for in ourselves and in the people we back.
Character, for us, is not a soft consideration set aside once the numbers are checked — it is the first thing we underwrite and the last thing we compromise on. A frontier punishes the people who oversell and protects the people who tell the truth, because reality eventually arrives and settles every account. So we watch how a founder describes the parts of the work that are not going well, whether they can separate what they know from what they hope, and whether they make commitments they can keep. We have learned to trust the operators who are precise about their own limits, because precision about limits is usually a sign of precision everywhere else. The crossings that matter take years, and the people who finish them are rarely the loudest at the outset — they are the ones still standing, still honest, and still trusted by their crew when the easy part is long behind them.
We are equally interested in the shape of the business. Durable value, to us, means something more than momentum. It means a reason the business should exist a decade from now: a structural advantage, an asset that compounds, a relationship with customers that deepens rather than erodes, or a position in a market that strengthens as the market matures. We would rather understand one genuine source of durability than count a long list of features. Frontiers are exciting precisely because they are unproven, but excitement is not a strategy — we want to see the path from a bold idea to a business that can stand on its own. We try to be specific with ourselves about where that durability actually comes from, because a vague answer to that question is usually a sign there is no answer at all. The businesses we admire tend to get stronger as they grow rather than more fragile, accumulating advantages that are hard to copy and harder to dislodge, so that time becomes an ally rather than a threat.
Alignment matters to us as much as ambition. We invest with the expectation of being long-term partners, and we look for people who want partners rather than passengers. That means shared incentives, honest reporting in good times and bad, and a willingness to have the difficult conversation early rather than late. We would rather hear about a problem while it is still small and fixable than read about it once it has grown beyond repair, and we try to be the kind of partner who makes that early honesty easy rather than costly. We are founder-led — the firm is built and run by Jason Kumpf, supported by a wider network of seasoned professionals we trust across the sectors we explore. That structure shapes how we behave: we are direct, we are accountable for our own decisions, and we are candid about what we do and do not know. It also keeps us close to the work, because the person making the decision is the person living with its consequences, and that proximity is something we value rather than something we try to scale away.
A frontier is not crossed in a single step, and neither is the life of a company. We invest across the full lifecycle — from the earliest angel checks, when an idea is little more than a conviction and a person, through the growth rounds that turn a working business into a lasting one, and into public-company positions where the question shifts from whether something can work to how well it will compound over time. We are comfortable at each of these stages because the underlying question never really changes: are these the right people, building something durable, on a frontier worth crossing? What changes is the evidence available to answer it, and our criteria shift accordingly.
At the earliest point — angel and seed — there is rarely a track record to lean on. Here we are underwriting people and the shape of the opportunity more than any results. We look for founders who see something true that others have missed, who can attract the first believers around them, and who learn faster than the problem evolves. The ambiguity is the point; we accept that most of what we are backing is still a hypothesis, and we weight character, insight, and the size of the frontier accordingly.
As a company moves into Series A and B, the question becomes whether the early signal is real and repeatable. We pay attention to whether the team has found genuine pull from the market rather than manufactured interest, whether the model holds together as it scales, and whether the founders are building the organization and discipline that growth demands. This is often the stage where character meets reality most directly: the founder who was right about the problem now has to become right about people, process, and pace, and not everyone makes that turn. We look for leaders who are growing as fast as the company is, who are honest about which instincts to keep and which to retire, and who are assembling a crew rather than simply hiring headcount. By Series C and D, we expect the core to be proven and the conversation to turn toward durability and scale: the strength of the competitive position, the quality of the unit economics, the depth of the leadership team, and the path toward a business that can stand independently — whether through continued growth, public markets, or strategic outcomes. The questions here are less about whether something can work and more about how well it will hold up under weight, against competition, and across the cycles that any lasting business has to survive.
And we do not stop at the threshold of the public markets. We hold positions in public companies where we believe the same things we look for privately are present — bold leadership, durable advantage, and a frontier still being crossed — and where the market's view diverges from our own considered conviction. Investing across this full range is deliberate. It lets us follow conviction wherever a company is in its life, support the people we back as their needs change, and bring perspective from one stage to bear on another. A frontier mindset at the earliest checks informs how we read a public company; the discipline of public-market durability informs how we underwrite the earliest bets.
Some sectors are not just growing — they are redrawing the map. These are the areas where we spend the most time, because they sit at the edge of what science and technology can now do and because the companies built there have the chance to create value that compounds for a long time. We invest across these frontiers from early stage through growth. What follows is how we think about each, and what a strong company in the space tends to look like. We hold these views with conviction and with humility: frontiers move, and we expect our understanding to keep moving with them.
Quantum technologies sit at one of the most genuine frontiers in computing and sensing. The promise is not incremental — it is a different way of representing and manipulating information that, for certain classes of problems, could do what classical machines cannot. We find the space compelling precisely because it is hard and early. The physics is real, the engineering challenges are immense, and the gap between a laboratory demonstration and a dependable system is exactly the kind of crossing that rewards bold, patient operators. Why now: the field has moved from pure theory toward working hardware, error-correction approaches are maturing, and a real ecosystem of talent, tooling, and early applications is forming around the technology rather than around a single demonstration.
A strong quantum company, to us, is one that is honest about where the science stands and disciplined about where it can create value before full-scale machines arrive. We look for teams with deep technical command who can articulate a credible path through the engineering, not just the physics — whether that path runs through hardware, error correction, control systems, software, or the sensing and security applications that may arrive sooner. We are wary of hype and drawn to teams who can explain what is genuinely hard, what they have actually solved, and why their approach has a durable advantage. The frontier here is long, and we value operators who are building for the crossing rather than for the next announcement.
What we weigh, in practice, is the gap between demonstration and dependability — and whether the team has a believable plan for closing it. We are interested in approaches that build defensibility into the foundation: hard-won engineering, accumulated know-how, intellectual property, or a position in the surrounding ecosystem of tooling and talent that becomes harder to displace over time. Because the full promise of the technology may still be years out, we pay close attention to how a company intends to create real value along the way rather than waiting for a single distant milestone. The operators who fit this frontier tend to combine the patience of scientists with the pragmatism of builders: they can sit with a problem that resists quick answers, yet they are restless about turning capability into something a customer will actually rely on. That pairing is rare, and it is much of what we are looking for here.
Artificial intelligence is reshaping how software is built, how work gets done, and what kinds of products are even possible. We treat it as a genuine frontier rather than a feature: a shift in capability broad enough that it is opening entirely new categories of business while transforming established ones. Why now is straightforward — the underlying models have crossed a threshold of usefulness, the tooling around them is maturing quickly, and the constraint is increasingly shifting from whether something is technically possible to who can build the most durable, trusted product on top of it.
Because so much attention flows to this space, our criteria here lean hard on durability. A strong AI company, in our view, is one whose advantage does not evaporate the moment the underlying models improve. We look for businesses with a defensible position — proprietary data, a deep workflow integration, a distribution advantage, real trust with customers, or genuine technical depth — rather than a thin layer that anyone could rebuild. We pay close attention to whether a company is solving a real problem that someone will pay for reliably, how it thinks about safety and responsibility, and whether the founders understand both the technology and the domain they are applying it to. On a fast-moving frontier, the operators who win are usually those who pair technical fluency with deep customer understanding and the judgment to build something people can depend on.
The question we keep returning to is what about this business compounds. A model improving is good for everyone and therefore an advantage for no one in particular; the companies that endure tend to own something that gets better with use — a data asset that deepens, a workflow that becomes load-bearing, a relationship of trust that is hard to re-earn elsewhere. We are drawn to founders who treat the underlying technology as a fast-moving current to ride rather than a moat to defend, and who are clear-eyed that their durability has to come from somewhere the current cannot wash away. We also take responsibility seriously here, not as a constraint bolted on at the end but as part of building something people can rely on: how a company handles trust, safety, and the consequences of being wrong is, to us, a real indicator of whether it will still be standing when the novelty wears off and only the dependable products remain.
Financial technology continues to remake how money moves, who has access to it, and how risk is priced and managed. We find it compelling because it sits at the intersection of large, essential markets and persistent friction — areas where better infrastructure, better access, and better experiences can create lasting value. Why now: the rails underneath finance are modernizing, regulation and capability are converging in new ways, and the combination of data, automation, and new distribution is letting well-run companies serve customers that legacy systems served poorly or not at all.
Fintech is also a space where discipline matters more than almost anywhere else, because trust, compliance, and unit economics are not optional. A strong fintech company, to us, is one that treats regulation and risk as core competencies rather than obstacles, that has a clear and honest view of how it makes money, and that builds genuine durability through trust, data, or infrastructure rather than through promotion. We look for operators who understand the systems they are working within deeply enough to change them responsibly, and who are building toward a defensible position rather than chasing growth that the economics cannot support. The frontier in fintech is rarely about novelty for its own sake; it is about doing something essential meaningfully better, and building the discipline to keep doing it as the company scales.
What we weigh here is whether the company has earned the right to handle other people's money — and whether it behaves that way at every level. Trust in finance is built slowly and lost quickly, so we look for teams that build margin for error into the foundation: sound risk management, an honest accounting of how losses and obligations are recognized, and a relationship with regulation that is collaborative rather than adversarial. We are wary of growth that depends on subsidies that cannot last or on costs that have simply been pushed into the future, and we are drawn instead to economics that hold up under scrutiny and improve as the company gains scale. The operators who fit this frontier tend to be the ones who find the work of compliance and risk genuinely interesting rather than tedious, because that is usually a sign they understand the system well enough to improve it without breaking the trust it depends on.
Biotechnology is one of the oldest frontiers and one of the most alive. The ability to understand and engineer biology is advancing in ways that touch medicine, agriculture, materials, and far beyond — and the potential to improve and extend lives gives the work a weight that few sectors carry. We are drawn to it because the upside is measured not only in business terms but in human ones, and because building a real biotech company demands an unusual blend of scientific depth, operational patience, and resilience. Why now: the tools to read, write, and manipulate biology have improved dramatically, the cost and speed of experimentation have shifted, and the convergence of biology with computation is opening approaches that were not feasible before.
A strong biotech company, in our view, is grounded in real science and led by people who can carry that science through the long, uncertain path to impact. We look for genuine differentiation in the underlying approach, a clear-eyed understanding of the development and regulatory road ahead, and leadership that can hold a team and a thesis together through the inevitable setbacks that biology delivers. We are interested in the science, but we are equally interested in the operators — because in biotech, the crossing is long, and the people who complete it are those who pair conviction with extraordinary discipline. We back this frontier knowing the road is hard, because the destinations are worth reaching.
Much of what we weigh in biotech is how a team holds up against time and against bad news, because both arrive in abundance. The path from a promising result to a product that reaches people is long, capital-intensive, and full of moments where the data does not cooperate, and we look for leaders who can absorb those moments without losing the thread or the trust of the people around them. We pay attention to whether the underlying advantage is real and defensible — a platform, a body of know-how, a position that others cannot easily reproduce — rather than a single result that may or may not generalize. And we look for an honest reckoning with the regulatory and development road ahead, because the teams that plan for that road tend to be the ones still moving when others have stalled. The weight of the work, measured in human terms, is exactly what draws us to it, and it is why we care so much about the seriousness of the people doing it.
Genetics is where biology becomes legible and, increasingly, editable. The ability to read genomes affordably and to edit them with growing precision is changing how we understand disease, how therapies are designed, and how we think about the foundations of living systems. We find this frontier compelling because it sits upstream of so much else — advances here ripple through medicine, agriculture, and our basic understanding of ourselves. Why now: sequencing has become broadly accessible, editing tools have matured from possibility into practice, and the combination of genetic data with computation is turning a flood of information into genuine insight.
A strong company in genetics, to us, is one that pairs real scientific and technical capability with a thoughtful grasp of the responsibility the field carries. We look for teams with a defensible foundation — whether in the underlying science, the platform, the data, or the application — and a clear path from capability to durable value. Because this frontier touches such fundamental territory, we pay particular attention to how a team thinks about safety, ethics, and the long-term consequences of what they are building. The operators we are drawn to here are those who hold both the ambition to push the frontier and the seriousness it demands. This is a crossing into deeply consequential territory, and we want partners who treat it that way.
What we weigh, beyond the science itself, is whether a company has built something that compounds rather than something that can be replicated the moment it is described. In a field moving this quickly, a clever idea is rarely enough on its own; the durable positions tend to rest on a platform that improves with use, a data asset that deepens over time, or accumulated capability that is genuinely hard to reproduce. We also believe that seriousness about ethics and seriousness about building are not in tension — the teams that think most carefully about consequences are often the same teams thinking most carefully about everything else. So when we meet operators who can hold the ambition and the responsibility together without flinching from either, we take it as a strong signal. The territory here is foundational enough that we would rather move with people who feel its weight than with people who do not.
Neurotechnology aims at one of the last and most profound frontiers: the brain itself. Efforts to understand, interface with, and support the nervous system carry implications for medicine, for how we treat conditions that have long resisted treatment, and ultimately for how humans interact with machines and with one another. We are drawn to this space because it is early, because it is hard in ways that demand genuinely original engineering and science, and because the potential to relieve real suffering gives it lasting significance. Why now: advances in sensing, materials, computation, and our understanding of neural systems are converging, moving parts of the field from speculation toward early, real-world application.
A strong neurotechnology company, in our view, is one that respects both the enormity of the science and the seriousness of working at the edge of the human body and mind. We look for deep, credible technical foundations, a clear sense of where genuine value can be created on a realistic horizon, and leadership that approaches safety, ethics, and patient trust as central rather than peripheral. Because the frontier here is so early, we value operators who can articulate honestly what is hard, what is unproven, and what they have actually demonstrated. This is a long voyage into the least-mapped territory of all, and we want to back the people with the rigor and the steadiness to make the crossing responsibly.
What we weigh most heavily in this space is the honesty of the horizon a team sets for itself. The brain does not yield to enthusiasm, and the distance between an early result and a dependable application can be long; the operators we trust are the ones who plan for that distance rather than wishing it away. We pay attention to whether a company has identified a place where it can create real, defensible value on a realistic timeline — often beginning with the clearest and most pressing medical needs — rather than promising the most dramatic possibilities first. And because the work touches people at their most vulnerable, we treat a team's seriousness about safety and trust as inseparable from its quality as a business. The crossing here is among the hardest there is, which is precisely why the rigor and steadiness of the people matter more, not less.
Longevity is the frontier aimed at extending not just the length of life but the span of healthy, capable years within it. The science of aging is moving from description toward intervention, as researchers begin to understand the underlying biology of aging well enough to imagine acting on it. We find this compelling because the potential impact is enormous and deeply human, and because building a serious longevity company requires patience, scientific honesty, and a long view — exactly the qualities we look for in the operators we back. Why now: aging biology is maturing as a field, new tools allow the underlying mechanisms to be studied and targeted directly, and the convergence with genetics, biotech, and computation is opening approaches that were previously out of reach.
A strong longevity company, to us, is one grounded in rigorous science rather than the marketing that too often surrounds the topic. We look for genuine scientific differentiation, a realistic and disciplined understanding of the long development path ahead, and leadership that can distinguish credible work from wishful thinking and hold a team to that standard. Because the field invites both real breakthroughs and real overstatement, we place particular weight on intellectual honesty and on operators who are building for durable impact rather than near-term attention. This is among the most ambitious frontiers there is, and we are drawn to the people willing to cross it carefully, for the right reasons, over the long horizon it demands.
More than in almost any other area, what we are weighing in longevity is the line between conviction and wishful thinking — and whether a team can hold it under pressure. The subject draws attention precisely because the prize is so large and so human, and that attention rewards overstatement unless a company deliberately resists it. So we look for operators who are most careful exactly where it would be easiest to oversell, who measure their work against the standards of serious science rather than the appetites of an audience, and who are building toward durable impact rather than the next encouraging headline. We also look for a defensible foundation beneath the ambition, because the long horizon this work requires can only be funded by a business that creates real value along the way. The crossing here is among the longest we consider, and we want partners with the patience and the honesty to make it for the right reasons.
Not every frontier is found at the earliest stage of a new technology. Some of the most durable value sits in established, cash-generative, or asset-backed businesses that are entering a new chapter — companies with real operations, real customers, and real assets, where disciplined ownership and capital can help build something that lasts. Alongside our work at the frontier of new technologies, we invest in the growth of more mature companies in areas we understand and find compelling. Here our criteria shift toward the tangible: the quality of the assets, the durability of the cash flows, and the strength of the operators running the business. The frontier mindset still applies — we are looking for a worthwhile crossing and the right people to lead it — but the evidence is grounded in operations rather than in possibility.
Real estate is among the most enduring forms of value there is — backed by physical assets, tied to real demand, and capable of compounding over long horizons when it is owned and operated well. We are drawn to it because it grounds a portfolio in tangible, durable assets and because thoughtful, disciplined operators can create lasting value through how property is acquired, improved, and managed over time. We are interested in opportunities where there is a clear reason the asset should appreciate or generate durable income, where the operating discipline is genuine, and where the people involved understand the markets and the assets deeply. What we look for is durability rather than speculation: real demand, sound fundamentals, and operators who treat the long-term stewardship of an asset as seriously as the transaction that begins it.
A strong real estate opportunity, to us, rests on something more concrete than the hope that prices will rise. We want to understand where the value actually comes from — a location with lasting demand, an asset that can be improved and operated better, income that holds up across cycles — and we want operators whose discipline shows in the details rather than in the pitch. We pay attention to how a team manages risk through leverage, timing, and the cycles that real estate inevitably moves through, because the difference between a durable position and a fragile one often lies there. We are drawn to people who treat ownership as stewardship: who maintain and improve what they hold, who build real relationships in the markets they operate in, and who measure success over years rather than quarters. Real estate, done with that discipline, is one of the steadiest harbors from which to support bolder crossings elsewhere.
Medical equipment companies sit at a meaningful intersection: they serve essential, durable demand within healthcare, and the better ones build defensible positions through quality, trust, regulatory standing, and the relationships they hold with the institutions that depend on them. We find this area compelling because the demand is real and lasting, because well-run companies here generate dependable value, and because there is room for established businesses to grow through better operations, expanded reach, and disciplined investment. What we look for is a genuine, durable position — products that institutions rely on, a sound regulatory and quality foundation, and leadership that understands both the operational and the clinical realities of the field.
The durability we look for in this space tends to come from trust that has been earned slowly and is hard for a competitor to take away. When a hospital or clinic depends on a piece of equipment and the company behind it, that relationship — built on reliability, service, regulatory standing, and the cost of switching — becomes a real and lasting position. So we weigh the quality and regulatory foundation of the business closely, because in healthcare those are not formalities but the basis of the trust the whole enterprise rests on. We are interested in companies where growth can be built responsibly on top of a real, cash-generative base — through better operations, broader reach, or disciplined investment — rather than growth that strains the standards the field demands. And we look for leadership that understands both sides of the work, the operational and the clinical, because the people who hold those two realities together tend to be the ones who can grow a healthcare business without compromising what made it trusted in the first place.
Telecommunications is the infrastructure beneath nearly everything else — the rails over which the modern economy and the frontiers we invest in actually run. We are drawn to the sector because it combines essential, durable demand with real, often asset-backed positions, and because well-run telecom businesses can generate dependable cash flows while serving needs that only grow over time. Our interest is in established companies with genuine infrastructure or market positions, where disciplined ownership and investment can support durable growth. What we look for is the durability of the underlying demand, the strength and defensibility of the assets or position, and operators who understand the economics and the technology deeply enough to build for the long term.
What makes telecom durable, in our view, is that the demand beneath it rarely retreats and the assets behind it are genuinely hard to reproduce — networks, infrastructure, and positions that take years and real capital to build. We weigh how defensible that position actually is, how the underlying demand is likely to hold and grow, and whether the operators understand both the economics and the technology well enough to keep the asset relevant as the technology around it shifts. We are drawn to people who treat infrastructure as something to be invested in and maintained rather than merely harvested, because the businesses that endure here are the ones whose owners keep them current rather than letting them quietly decay. Telecom is rarely about novelty; it is about owning something essential and operating it with discipline — and we value the people who do exactly that, because the rails they maintain make every other crossing possible.
If there is a single through-line across everything we invest in, it is this: bold people, building on new frontiers, creating value that lasts. Across stages — from the first angel check to public-company ownership — and across the spirit of the earliest venture voyages, the question we are really asking never changes. Are these the right people? Is the frontier worth crossing? Will what they build still matter when the crossing is complete? Whether the opportunity is a quantum hardware team, a disciplined fintech company, a longevity platform grounded in real science, or an asset-backed business entering a new chapter, those three questions are what we come back to.
We are honest about who we are. We are a founder-led firm, built and run by Jason Kumpf with the support of a wider network of seasoned professionals we trust across the areas we explore. We are building our record deliberately, and we care far more about the quality and durability of what we back than about how large we become. We are excited about outcomes — about companies that endure, technologies that change what is possible, and operators who become long-term partners — and that excitement is grounded, not inflated. We would rather be candid about what we do not yet know than promise certainty we cannot offer.
What makes a fit, in the end, is alignment on all of it: the kind of operator we are drawn to, the kind of durability we look for, and the kind of partnership we want to build. We invest with conviction rather than consensus, we hold a long view, and we mean it when we say we want to be partners through the full length of the voyage rather than passengers along for part of it.
If that sounds like what you are building, we would like to hear from you. The best conversations start simply: tell us what frontier you are crossing, why now, and why you are the people to do it. The first venture voyages began with exactly that kind of conversation — a clear-eyed account of the crossing ahead and the conviction to make it. We are always glad to begin one.